Literature DB >> 17132944

Inhibition of HIV-1 replication by an improved hairpin ribozyme that includes an RNA decoy.

Alicia Barroso-DelJesus1, Elena Puerta-Fernández, Natalia Tapia, Cristina Romero-López, Francisco José Sánchez-Luque, Miguel Angel Martínez, Alfredo Berzal-Herranz.   

Abstract

An anti-Tat hairpin ribozyme and a TAR RNA decoy were combined in one molecule. The chimeric molecule strongly inhibited HIV-1 replication (measured as changes in p24 levels in viral replication assays). The inhibitory action of the ribodecozyme (85%) was significantly greater than that shown by ribozyme and a non-catalytic variant carrying the functional decoy RNA domain (55% and 35%, respectively). This represents a significant improvement of the inhibitory efficiency of the ribozyme, suggesting there is an additive inhibitory effect on HIV-1 replication by the catalytic and decoy domains. This strategy could be used to create new inhibitor RNAs with enhanced in vivo performance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17132944     DOI: 10.4161/rna.2.2.2044

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  3 in total

1.  Inhibition of HIV-1 replication and dimerization interference by dual inhibitory RNAs.

Authors:  Francisco J Sánchez-Luque; José A Reyes-Darias; Elena Puerta-Fernández; Alfredo Berzal-Herranz
Journal:  Molecules       Date:  2010-07-07       Impact factor: 4.411

2.  Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.

Authors:  Martin R Jakobsen; Joost Haasnoot; Jesper Wengel; Ben Berkhout; Jørgen Kjems
Journal:  Retrovirology       Date:  2007-04-26       Impact factor: 4.602

3.  Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies.

Authors:  Francisco J Sánchez-Luque; Michael Stich; Susanna Manrubia; Carlos Briones; Alfredo Berzal-Herranz
Journal:  Sci Rep       Date:  2014-09-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.